ARCHIVES

In Brief: Smyth Moves From AOR To Bristol-Myers; Lurie Center Wins Grants From Army, NCI

This article is from The Cancer Letter archive.

Vol. 22 No. 48 | December 13, 1996

Download PDF Visit The Full Archive

Related Articles

DeVita’s “Radical” Statement – Resectability Rate Should Be The Cure Rate

October 1, 1976

Erbitux Plus Radiation, Chemo, Appears To Provide CRs In A Small Phase II Study

February 23, 2007

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

June 5, 2009

Full Text Of NCI-Specific Language In House Report

July 31, 1992

Interview: Joseph Jacobs Claims “Political Extortion” By The “Harkinites”

October 14, 1994

AACR, ASCO Publish Reports Examining U.S. Cancer Care

April 4, 2014